Abbvie (ABBV) PT Lowered to $80 at Piper Jaffray
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Wolfe Research Upgrades Abbvie (ABBV) to Peerperform on Valuation
June 27, 2019 9:30 AM EDTWolfe Research analyst Tim Anderson upgraded Abbvie (NYSE: ABBV) from Underperform to Peerperform with a price target of $74.00 (from $84.00).
Cites the recent pullback in the valuation for the upgrade.For an analyst ratings summary and ratings history on... More
